Skip to Content
  • Revenues ($M)$153,290
  • Revenue Percent Change10%
  • Profits ($M)$5,237
  • Profits Percent Change12.8%
  • Assets ($M)$93,657
  • Employees199,000
  • Market Value — as of March 31, 2016 ($M)$113,947
  • Previous Rank10
  • Morning Consult Brand Index
    A

CVS Health is still feeling the pinch from its 2014 decision to drop cigarettes. But the company continues to leverage the positive PR to convince more employers that it’s truly a health care company, allowing it to win new business for its Caremark pharmacy benefits manager. Though the PBM eclipsed its retail drugstore business in size a few years ago, the company continued expanding its CVS/pharmacy business, which has been grappling with declines in comparable sales. CVS recently took over 1,700 in-store drugstores from Target and is rolling out order pickup with tech startup Curbside this year. It is also continuing to push healthier food options in its stores to burnish its image as a healthcare company and improve its beauty selection to better compete with arch-rival Walgreens.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Larry J. Merlo
Sector
Food and Drug Stores
Industry
Food and Drug Stores
HQ Location
Woonsocket, RI
Websitehttp://www.cvshealth.com
Years on Fortune 500 List22
Employees199,000
Acquired Omnicare (2014 rank: 414), Aug. 18, 2015.

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$153,29010%
Profits ($M)$5,23712.8%
Assets ($M)$93,657-
Total Stockholder Equity ($M)$37,196-
Market Value — as of March 31, 2016 ($M)$113,947-

Profit Ratios

Profit as % of Revenues3.4%
Profits as % of Assets5.6%
Profits as % of Stockholder Equity14.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)4.63
EPS % Change (from 2014)16.9%
EPS % Change (5 year annual rate)13.2%
EPS % Change (10 year annual rate)12.3%

Total Return

Total Return to Investors (2015)2.9%
Total Return to Investors (5 year, annualized)24.8%
Total Return to Investors (10 year, annualized)15.3%